Calendar · pharmadog

Sign In Subscribe

Date TBD

21

COMPLETEDphase readoutNCT04766684: Clubfoot Tenotomy Trial

Sponsor: Vanderbilt University Medical Center. Phase: PHASE4. Conditions: Clubfoot

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07631884: Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor

Sponsor: Haihua Yuan. Phase: PHASE2. Conditions: Solid Tumors, Neoplasms (Cancer / Tumors), Advanced Malignant Solid Neoplasm, Locally Advanced Malignant Solid Neoplasm, Unresectable Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, HER2 Expression, Biliary Tract Neoplasms, Endometrial Neoplasms, Urothelial Carcinoma (UC), Pancreatic Neoplasms, Colorectal Neoplasms, Gastric Neoplasms, Non-Small Cell Lung Carcinoma (NSCLC), Head and Neck Neoplasms, Cervical Neoplasms

full page →ctgov ↗

RECRUITINGphase readoutNCT07087184: Gauging Outcomes of Total Milk Ingestion on Lipid and gControl

Sponsor: University of California, San Francisco. Phase: NA. Conditions: Heart Diseases, Cardiovascular Disease

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05416333: Azelaic Acid as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)

Sponsor: Wake Forest University Health Sciences. Phase: EARLY_PHASE1. Conditions: Central Centrifugal Cicatricial Alopecia

full page →ctgov ↗

RECRUITINGphase readoutNCT06865638: Efficacy and Safety of Colorectal Anastomotic Leak Testing

Sponsor: Nanchong Central Hospital. Phase: NA. Conditions: Colorectal Cancer, Leakage Testing, Colorectal Surgery, Complications, Anastomotic Leakage

full page →ctgov ↗

RECRUITINGphase readoutNCT06835738: Implementation of Multiple Micronutrient Supplementation (MMS) for Pregnant Women in Uganda

Sponsor: Johns Hopkins Bloomberg School of Public Health. Phase: NA. Conditions: Nutrient Deficiency

full page →ctgov ↗

RECRUITINGphase readoutNCT07284758: A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

Sponsor: C4 Therapeutics, Inc.. Phase: PHASE2. Conditions: Multiple Myeloma, Relapsed/Refractory Multiple Myeloma

full page →ctgov ↗

RECRUITINGphase readoutNCT07374848: Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected Tumors

Sponsor: Zai Lab (Shanghai) Co., Ltd.. Phase: PHASE1. Conditions: Solid Tumors, Sarcomas

full page →ctgov ↗

RECRUITINGphase readoutNCT07668648: Interscalene Brachial Plexus Block Versus Serratus Posterior Superior Intercostal Plane Block for Arthroscopic Shoulder Surgery

Sponsor: Ferit Yetik. Phase: NA. Conditions: Postoperative Pain, Shoulder Arthroscopy

full page →ctgov ↗

RECRUITINGphase readoutNCT06958848: 16F vs 24F Chest Drain After Minimally Invasive Lobectomy and/or Segmentectomy

Sponsor: University Hospital, Basel, Switzerland. Phase: NA. Conditions: Pneumothorax, Pleural Effusion

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT05101148: Phase I Study to Assess the Effect of Food on the PK and Gastrointestinal Tolerability of Selumetinib in Adolescent Children With Neurofibromatosis Type 1 Related Plexiform Neurofibromas

Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Neurofibromatosis Type 1

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT01575548: Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery

Sponsor: National Cancer Institute (NCI). Phase: PHASE3. Conditions: Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v7

full page →ctgov ↗

RECRUITINGphase readoutNCT07406048: Real-World Effectiveness of a Triple Combination BDP/FF/GB Extrafine in a Single Pressurised Metered Dose Inhaler in Brazilian COPD Patients

Sponsor: Chiesi Farmaceutica Ltda.. Phase: . Conditions: COPD (Chronic Obstructive Pulmonary Disease)

full page →ctgov ↗

RECRUITINGphase readoutNCT06761326: Right Versus Left Distal Axillary Vein Cannulation

Sponsor: Alexandria University. Phase: NA. Conditions: Infraclavicular Vein Cannulation, Venous Cannulation

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04208178: Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA Mutation

Sponsor: Novartis Pharmaceuticals. Phase: PHASE3. Conditions: Advanced HER2+Breast Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT07714785: Impact of EEG-guided Sevofluorane on Opioid Consumption and Quality of Awakening

Sponsor: Pontificia Universidad Catolica de Chile. Phase: NA. Conditions: Pediatric Anesthesia, Emergence Delirium, Anesthesia, Postoperative Pain, Tonsillectomy

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07645885: Fermented Foods and Bone Health: Investigating the Gut-Bone Axis in Premenopausal Vegan Women

Sponsor: Isabelle Herter-Aeberli. Phase: NA. Conditions: Bone, Bone Health

full page →ctgov ↗

RECRUITINGphase readoutNCT07482943: The Effect of Dapagliflozin on Exercise and Cardiac Functional Status of Patients After Fontan Procedure

Sponsor: The University of Hong Kong. Phase: PHASE4. Conditions: Fontan, Heart Failure, Dapagliflozin, Cardiovascular Diseases, Sodium-GLucose coTransporter-2 Inhibitors

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06604715: A Study of JNJ-87562761 in Participants With Relapsed or Refractory Multiple Myeloma

Sponsor: Janssen Research & Development, LLC. Phase: PHASE1. Conditions: Relapsed or Refractory Multiple Myeloma

full page →ctgov ↗

COMPLETEDphase readoutNCT04670835: Modeling the Impact of Inbound Call Distribution Virtualization in Emergency Medical Communication Centers (EMCCs) on Their Service Level

Sponsor: Nantes University Hospital. Phase: . Conditions: Emergency Medical Service Communication Systems, Health Care

full page →ctgov ↗

COMPLETEDphase readoutNCT07083908: A Comparison of THD® Anopress With High Resolution Anorectal Manometry

Sponsor: King's College Hospital NHS Trust. Phase: NA. Conditions: Obstetric Anal Sphincter Injury

full page →ctgov ↗